Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Discover the full record of transactions filed by Finkelstein J J, Chief Executive Officer. Officer active across 1 company, notably Regenerx Biopharmaceuticals INC. Cumulatively, 1 reports have been logged. Split: 1 buy · 0 sell. Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
FINKELSTEIN J J serves as President and CEO at Regenerx Biopharmaceuticals Inc. He is responsible for the strategic and operational direction of the company. J J plays a key role in business development and technological innovation, contributing to the growth of Regenerx. His expertise in the biopharmaceutical sector is essential for navigating a competitive environment.